Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZFAND2AP1 (ZFAND2A pseudogene 1) is a processed pseudogene derived from the ZFAND2A gene, which encodes AN1-type zinc finger protein 2A[9][11]. Pseudogenes like ZFAND2AP1 lack the ability to encode a functional protein, as they typically result from duplication or retrotransposition events and accumulate mutations that disrupt protein-coding potential[4]. While some pseudogenes can play regulatory roles at the transcript level (for example, by acting as decoys for microRNAs or influencing the expression of related genes), there is currently no evidence that ZFAND2AP1 encodes a protein or acts as a functional target in therapeutic contexts[11][9][4]. Thus, ZFAND2AP1 is not considered a therapeutic target, receptor, or an enzyme. Pseudogenes in general can sometimes contribute to disease mechanisms, primarily through regulatory effects on their parent genes, but there is no current evidence or broad consensus suggesting ZFAND2AP1 specifically has such a role. If you are seeking information about a therapeutic target, verify whether you intended the functional gene (ZFAND2A) rather than the pseudogene (ZFAND2AP1) for your query[13][14].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZFAND2A pseudogene 1 (ZFAND2AP1).